Tag: Suboxone

According to the National Institute on Drug Abuse (NIDA), methadone and buprenorphine are equally effective medications for treating opioid use disorder (OUD). In the context of OUD treatment, the drug most pharmacologically comparable and functionally closest to methadone is buprenorphine.

In a 2024 study, 50% of patients with opioid use disorder (OUD) who received buprenorphine in the emergency department remained engaged in treatment after one month [1.4.1]. So, what is the street name for buprenorphine, and why is this medication so prevalent?

In 2022, an estimated 9.3 million U.S. adults needed treatment for Opioid Use Disorder (OUD), yet only about 25% received medication for it [1.6.1, 1.6.4]. Understanding **how to qualify for Suboxone** is a critical first step toward accessing this effective treatment.

According to the Substance Abuse and Mental Health Services Administration (SAMHSA), buprenorphine was the first medication for opioid use disorder (OUD) that could be prescribed from a physician's office. Given its increasing use, many individuals wonder, **does Suboxone test positive for buprenorphine?** The answer is yes, but only if the test is specifically designed to detect it, as it will not typically appear on a standard drug panel.

Medications like buprenorphine for opioid use disorder (OUD) are associated with a 60% reduction in overdose risk and mortality. This article explains **what type of opiate is buprenorphine** and why its distinct pharmacological properties make it a vital tool in treating opioid dependency with a reduced potential for overdose.

In 2023, over 15 million buprenorphine prescriptions were dispensed in the United States [1.7.2]. A common question among users is, **can Suboxone affect your eyes?** The answer is yes, and this article explores how.

Over 2 million Americans have an opioid use disorder, and buprenorphine is a cornerstone of medication-assisted treatment for many of them. For those seeking to understand their treatment options or learn more about this medication, it is important to know what other drugs contain buprenorphine besides the well-known Suboxone.

As of 2024, millions of individuals in the United States suffer from opioid use disorder (OUD) or chronic pain, with buprenorphine being a crucial treatment for both conditions. This versatile medication is primarily known for its role in medication-assisted treatment (MAT) for opioid addiction but is also effective for managing severe, long-term pain. By acting as a partial opioid agonist, buprenorphine provides therapeutic benefits with a reduced risk profile compared to full opioid agonists.

According to the Centers for Disease Control and Prevention (CDC), millions of Americans are affected by opioid use disorder (OUD), a condition that medication-assisted treatment (MAT) can effectively manage. A crucial part of this treatment is understanding **who is a good candidate for buprenorphine** and what criteria determine eligibility for this life-changing medication.

According to the National Institute on Drug Abuse, Medication-Assisted Treatment (MAT) for opioid use disorder is often highly effective but can be costly. The Suboxone discount program, offered by the manufacturer via the INSUPPORT® program, provides financial assistance to eligible patients to help reduce these costs and improve access to treatment. This article will delve into the specifics of this program and other potential savings options.